GABRIELA HUNDORFEAN: Open Payments
NPI 1992875017 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 23 payments from 7 companies in 2025. Trend: 2023 $1,540 · 2024 $1,064 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $496 |
| E.R. Squibb & Sons, L.L.C. | 4 | $302 |
| Alkermes, Inc. | 2 | $250 |
| Janssen Pharmaceuticals, Inc | 3 | $118 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $83 |
| Lundbeck LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: ABILIFY MAINTENA, COBENFY, ARISTADA, VIVITROL, INVEGA SUSTENNA, ABILIFY ASIMTUFII, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
